Annie Lamont - HCA Holdings Independent Director
| HCA Etf | USD 297.00 14.03 4.51% |
Ms. Annie Huntress Lamont is an Independent Director of HCA Holdings, Inc., since May 9, 2013. Ms. Lamont was with Oak Investment Partners since 1982, serving as General Partner from 1986 to 2006 and as a Managing Partner since 2006. Ms. Lamont has also served as a director of Benefitfocus, Inc. since 2010 and a director of Castlight Health, Inc. since 2009. Ms. Lamont served as a director of NetSpend Holdings, Inc. from 2004 until 2013 and a director of athenahealth, Inc. from 2000 until 2010.
| Age | 60 |
| Tenure | 11 years |
| Address | One Park Plaza, Nashville, TN, United States, 37203 |
| Phone | 615 344 9551 |
| Web | https://www.hcahealthcare.com |
HCA Holdings Management Efficiency
The company has Return on Asset of 0.1108 % which means that on every $100 spent on assets, it made $0.1108 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1234 %, implying that it generated $0.1234 on every 100 dollars invested. HCA Holdings' management efficiency ratios could be used to measure how well HCA Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Richard Bracken | CVS Health Corp | 65 | |
| Kimberly Ross | Cigna Corp | 56 | |
| Tony White | CVS Health Corp | 73 | |
| Robert Ditmore | Centene Corp | 86 | |
| Anne Finucane | CVS Health Corp | 68 | |
| Valerie Rice | UnitedHealth Group Incorporated | 58 | |
| Daniel Cooperman | Molina Healthcare | 70 | |
| Edson Bueno | UnitedHealth Group Incorporated | 71 | |
| Dale Wolf | Molina Healthcare | 66 | |
| Frederick Eppinger | Centene Corp | 62 | |
| Mary Schapiro | CVS Health Corp | 65 | |
| Timothy Flynn | UnitedHealth Group Incorporated | 64 | |
| John Roberts | Centene Corp | 78 | |
| Mary Hoeltzel | Cigna Corp | N/A | |
| Glenn Renwick | UnitedHealth Group Incorporated | 64 | |
| Michele Hooper | UnitedHealth Group Incorporated | 68 | |
| Timothy | UnitedHealth Group Incorporated | 58 | |
| Jessica Blume | Centene Corp | 66 | |
| Rodger Lawson | UnitedHealth Group Incorporated | 69 | |
| Jane Henney | Cigna Corp | 69 | |
| Fernando Aguirre | CVS Health Corp | 64 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.11 |
HCA Holdings Money Managers
| William Rutherford, Chief Financial Officer, Executive Vice President | ||
| Kathleen JD, Senior Officer | ||
| Andrea Smith, Independent Director | ||
| Christopher Wyatt, Senior Vice President Controller | ||
| Michael Cuffe, Executive Vice President, Chief Clinical Officer | ||
| William Frist, Independent Director | ||
| Jonathan Perlin, President - Clinical and Physician Services Group, Chief Medical Officer | ||
| J Morrow, Senior Vice President - Finance, Treasurer | ||
| Robert Waterman, Senior Vice President General Counsel, Chief Labor Relations Officer | ||
| Terence Arkel, Chief Division | ||
| Geoffrey Meyers, Independent Director | ||
| Joseph Sowell, Senior Vice President Chief Development Officer | ||
| Charles Gressle, President Division | ||
| Jana Davis, Senior Vice President - Corporate Affairs | ||
| Dan Miller, President Division | ||
| Deborah Reiner, Senior Vice President of Marketing and Communications | ||
| Hugh Johnston, Independent Director | ||
| Timothy McManus, President Group | ||
| Donald Stinnett, Senior Vice President Controller | ||
| Arnold Moore, President - Service Line and Operations Integration | ||
| Jeff Cohen, Senior Vice President - Government Relations | ||
| Sammie Mosier, Senior Vice President Chief Nurse Executive | ||
| Juan Vallarino, Senior Vice President - Employer and Payer Engagement | ||
| Paul Paslick, Senior Vice President, Chief Information Officer | ||
| Joseph Steakley, Senior Vice President - Internal Audit Services | ||
| Erol FACHE, President Group | ||
| Thomas Frist, Chairman of the Board | ||
| Michael Marks, Senior Finance | ||
| Charles Holliday, Independent Director | ||
| Tim McManus, President of HCA's Capital Division | ||
| Annie Lamont, Independent Director | ||
| Jon Foster, President of American Group | ||
| Jay Light, Independent Presiding Director | ||
| Charles Hall, President of National Group | ||
| Bruce Moore, President - Service Line and Operations Integration | ||
| Wayne Riley, Independent Director | ||
| Samuel Hazen, Chief Executive Officer, Director | ||
| Greg Lowe, President Division | ||
| Milton Johnson, Chairman and CEO | ||
| David Anderson, Senior Vice President - Finance, Treasurer | ||
| Troy Villarreal, President - HCA's Gulf Coast Division | ||
| Michael Michelson, Independent Director | ||
| Lyn Ketelsen, Chief Patient Experience Officer | ||
| NancyAnn DeParle, Independent Director | ||
| John Rowe, Independent Director | ||
| John Steele, Chief Human Resource Officer, Senior Vice President | ||
| Robert Dennis, Independent Director | ||
| Chad Wasserman, Senior Officer | ||
| Sandra Morgan, Senior Vice President — Provider Relations | ||
| MD Frist, Founder Emeritus | ||
| Jane Englebright, Senior Vice President and Chief Nursing Officer | ||
| Michael McAlevey, Senior Vice President and Chief Legal Officer | ||
| Heather Rohan, President of HCA's TriStar Division | ||
| Martin Paslick, Senior Officer | ||
| Phillip Billington, Senior Vice President - Internal Audit Services | ||
| Kathryn Torres, Senior Vice President - Payer Contracting and Alignment | ||
| Jeffrey Cohen, Senior Relations | ||
| Ann Lamont, Independent Director | ||
| Alan Yuspeh, Senior Vice President Chief Ethics and Compliance Officer | ||
| Kathleen Whalen, Senior Vice President Chief Ethics and Compliance Officer | ||
| MD MBA, Executive Officer | ||
| William Morrow, Senior Vice President - Finance, Treasurer | ||
| Frank CFA, Vice Relations | ||
| Mark Kimbrough, Vice President - Investor Relations | ||
| Joseph III, Senior Officer | ||
| Jim Brown, Chief Center | ||
| Victor Campbell, Senior Vice President | ||
| Brian Cook, President Division | ||
| Meg Crofton, Independent Director | ||
| Ravi Chari, Senior Vice President - Clinical Excellence | ||
| Jennifer Berres, Chief Human Resource Officer, Senior Vice President |
HCA Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is HCA Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 122.23 B | ||||
| Shares Outstanding | 264.48 M | ||||
| Shares Owned By Insiders | 27.22 % | ||||
| Shares Owned By Institutions | 64.63 % | ||||
| Number Of Shares Shorted | 2.6 M | ||||
| Price To Earning | 13.57 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HCA Holdings. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade HCA Etf refer to our How to Trade HCA Etf guide.Note that the HCA Holdings information on this page should be used as a complementary analysis to other HCA Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
The market value of HCA Holdings is measured differently than its book value, which is the value of HCA that is recorded on the company's balance sheet. Investors also form their own opinion of HCA Holdings' value that differs from its market value or its book value, called intrinsic value, which is HCA Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HCA Holdings' market value can be influenced by many factors that don't directly affect HCA Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HCA Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if HCA Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HCA Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.